SHALL WE DANCE? EXTENDING TANGO’S RESULTS TO CLINICAL PRACTICE
Results from the TANGO study highlight the high efficacy and tolerability of lamivudine (3TC) and dolutegravir (DTG) as a switch strategy. However, trials’ populations often differ from real-practice settings. We aimed to confirm the study’s findings in our multicenter cohort. This was an observational study enrolling HIV-infected, virologically suppressed patients switching to 3TC+DTG, divided into…